Want to see HK:0570 full AI Analyst Report?
0570 Stock Chart & Stats
HK$1.40
HK$0.00(0.00%)
At close: 4:00 PM EDT
HK$1.40
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$1.22 - HK$2.68
Previous CloseN/A
Volume9.79M
Average Volume (3M)8.84M
Market Cap
HK$6.14B
Enterprise ValueHK$5.96K
Total Cash (Recent Filing)HK$4.56B
Total Debt (Recent Filing)HK$1.34B
Price to Earnings (P/E)―
Beta0.41
Next Earnings
Mar 19, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.29%
Share Statistics
EPS (TTM)-0.21
Shares Outstanding5,035,802,000
10 Day Avg. Volume11,156,972
30 Day Avg. Volume8,838,378
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)0.46
Price to Sales (P/S)0.64
P/FCF Ratio4.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.09
Revenue Forecast (FY)HK$12.98B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetLow leverage and substantial equity backing provide financial flexibility as the company navigates weaker earnings. Falling total debt reduces refinancing pressure and preserves capacity to support operations, invest in the TCM portfolio, or withstand prolonged demand softness.
Recent Cash GenerationStrong operating and free cash flow in the latest two years shows that the business is still converting activity into liquidity despite weaker reported earnings. This supports ongoing funding needs and provides a practical buffer while management works to restore profitability.
Healthy Gross Profit BaseA healthy gross profit base indicates that the company’s TCM products continue to generate value before operating costs and other items. This gives the business an earnings foundation that could support recovery if cost control and below-gross-profit performance improve.
Bears Say
Profitability DeteriorationThe shift from several years of profit to near-break-even and then a net loss signals a material weakening in earnings quality. Persistent losses can reduce retained capital, constrain reinvestment, and make future performance more dependent on an operating recovery.
Falling Revenue MomentumRepeated revenue declines after earlier growth suggest that demand, pricing, or channel execution has become less stable. Continued top-line contraction can reduce operating leverage, weaken the ability to absorb fixed costs, and make a return to sustainable profit more difficult.
Volatile Cash-flow DurabilityRecent positive cash generation is tempered by a history of negative free cash flow and a sharp slowdown in 2025 growth. Such volatility may reflect inconsistent conversion or working-capital swings, making liquidity planning and confidence in recurring cash generation more difficult.
China Traditional Chinese Medicine Holdings Co News
0570 FAQ
What was China Traditional Chinese Medicine Holdings Co Ltd’s price range in the past 12 months?
China Traditional Chinese Medicine Holdings Co Ltd lowest stock price was HK$1.22 and its highest was HK$2.68 in the past 12 months.
What is China Traditional Chinese Medicine Holdings Co Ltd’s market cap?
China Traditional Chinese Medicine Holdings Co Ltd’s market cap is HK$6.14B.
When is China Traditional Chinese Medicine Holdings Co Ltd’s upcoming earnings report date?
China Traditional Chinese Medicine Holdings Co Ltd’s upcoming earnings report date is Mar 19, 2027 which is in 179 days.
How were China Traditional Chinese Medicine Holdings Co Ltd’s earnings last quarter?
China Traditional Chinese Medicine Holdings Co Ltd released its earnings results on Aug 28, 2026. The company reported -HK$0.18 earnings per share for the quarter.
Is China Traditional Chinese Medicine Holdings Co Ltd overvalued?
According to Wall Street analysts China Traditional Chinese Medicine Holdings Co Ltd’s price is currently Overvalued.
Does China Traditional Chinese Medicine Holdings Co Ltd pay dividends?
China Traditional Chinese Medicine Holdings Co Ltd pays a Notavailable dividend of HK$0.086 which represents an annual dividend yield of 0.29%. See more information on China Traditional Chinese Medicine Holdings Co Ltd dividends here
What is China Traditional Chinese Medicine Holdings Co Ltd’s EPS estimate?
China Traditional Chinese Medicine Holdings Co Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Traditional Chinese Medicine Holdings Co Ltd have?
China Traditional Chinese Medicine Holdings Co Ltd has 5,035,802,000 shares outstanding.
What happened to China Traditional Chinese Medicine Holdings Co Ltd’s price movement after its last earnings report?
China Traditional Chinese Medicine Holdings Co Ltd reported an EPS of -HK$0.18 in its last earnings report. Following the earnings report the stock price went up 0.361%.
Which hedge fund is a major shareholder of China Traditional Chinese Medicine Holdings Co Ltd?
Currently, no hedge funds are holding shares in HK:0570
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
China Traditional Chinese Medicine Holdings Co Ltd
China Traditional Chinese Medicine Holdings Co. Limited functions as an investment holding company, primarily focusing on the research, development, and sale of traditional Chinese medicine and other pharmaceutical goods across the People's Republic of China. The company's product range includes medicinal granules, finished pharmaceutical preparations, pre-portioned decoction materials, and various healthcare products. Furthermore, its operations extend to the cultivation and management of Chinese medicinal herbs, the manufacturing of traditional Chinese medicines, and the trading of pharmaceutical products. It also delivers marketing, advertising, and consulting services related to TCM, and operates retail outlets for pharmaceuticals and decoction products. Property leasing services represent another facet of its business. The company distributes its products to healthcare facilities and retail pharmacies. Established in 1573 and headquartered in Wan Chai, Hong Kong, the firm was formerly known as China Traditional Chinese Medicine Co. Limited before adopting its current name in July 2016.
Technical Analysis
Guangzhou Baiyunshan Pharmaceutical Holdings Company
―
Wai Yuen Tong Medicine Holdings Limited
―
Grand Pharmaceutical Group Limited
―
Golden Throat Holdings Group Co Ltd
―
Shandong Xinhua Pharmaceutical Company Limited Class H
―